| 3C | chromosome conformation capture |
| 4C | circularized chromosome conformation capture |
| AR | Androgen Receptor |
| CNAs | Copy Number Alterations |
| CPC-GENE | Canadian CaP Genome Network |
| CR-NEPC | castration resistant neuroendocrine prostate cancer |
| CRPC | castration resistant prostate adenocarcinoma |
| DDR | Damage Repair |
| DSB | double-strand break |
| EGFR | epidermal growth factor receptor |
| FA | Fanconi anemia |
| FISH | fluorescent in-situ hybridization |
| HBOC | hereditary breast and ovarian cancer |
| HBOC | ovarian cancer |
| HPC | hereditary Prostate Cancer |
| HR | homologous recombination |
| HR | homologous recombination |
| ICGC | International Cancer Genome Consortium |
| LS MAPK |
Lynch Syndrome Mitogen-activated protein kinase |
| MATCH | Molecular Analysis for Therapy Choice |
| mCRPC | metastatic castrate resistant prostate cancer |
| MMR | Mismatch Repair |
| MSI | microsatellite instability |
| NCI | National Cancer Institute |
| NGS NIH |
Next-Gen sequencing National Institutes of Health |
| NHEJ | Non-homologous end joining |
| NSCLC | non-small-cell lung cancer |
| OMB PARP PI3K |
Office of Management and Budget Poly (ADP-ribose) polymerase Phosphatidylinositol 3- kinase |
| PCF | Prostate Cancer Foundation |
| SEER SNPs |
Surveillance, Epidemiology, and End Results single-nucleotide polymorphisms |
| SSA | single-strand annealing |
| SU2C | Stand Up to Cancer |
| TCGA | The Cancer Genome Atlas |
| TSG | tumor suppressor genes |
| WES | Whole exome sequencing |